Rat MRNA Expression Profiles Associated with Inhibition of Ischemic Acute Kidney Injury by Losartan

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2019 Mar 17

PMID 30877184

Citations 7

Authors

Yijin Wu

Wenying Peng

Ru Wei

Yanhe Zhou

Miaoxian Fang

Siyi Liu

Yujun Deng

Qi Yin

Xin Ouyang

Linhui Hu

Yating Hou

Chunbo Chen

Affiliations

Soon will be listed here.

Abstract

: Losartan was reported to inhibit the progression of acute kidney injury (AKI), but little is known about the underlying pharmacological mechanisms. In the present study, the mRNA expression profiles in ischemic AKI rat kidney altered by losartan treatment were analyzed by next-generation deep sequencing technology.: Ischemia and reperfusion treatment was applied to induce AKI in Sprague-Dawley (SD) rats. The urea and creatinine contents in rat blood were measured. H&E staining was performed to evaluate the histological alteration of rat kidney tissues under a microscope. The TUNEL method was applied to analyze apoptosis in rat kidney tissues. The mRNA profiles in rat kidney were analyzed using next-generation deep sequencing. Differential gene expression was confirmed by quantitative qRT-PCR.: The rat model of AKI induced by ischemia and reperfusion showed significant increases in urea and creatinine levels, accompanied by a disrupted kidney tubular structure and renal cell apoptosis. Losartan treatment effectively inhibited the changes in urea and creatinine, tubular structure, and apoptosis in AKI rat kidney. A large number of mRNAs were found to be differentially expressed in the kidneys of AKI rats treated with losartan, which are involved in multiple processes and signaling pathways. The expression of nine differentially expressed genes such as monocyte chemoattractant protein-1 (CCL2) and suppressor of cytokine signaling 3 (SOCS3) was confirmed by qRT-PCR and Western blot.: Losartan caused significant alterations in the gene expression profile in AKI rat kidney, which mediated its anti-AKI effects.

Citing Articles

A protein encoded by circular ZNF609 RNA induces acute kidney injury by activating the AKT/mTOR-autophagy pathway.

Ouyang X, He Z, Fang H, Zhang H, Yin Q, Hu L Mol Ther. 2022; 31(6):1722-1738.

PMID: 36110046 PMC: 10277836. DOI: 10.1016/j.ymthe.2022.09.007.

The Interaction of Central Nervous System and Acute Kidney Injury: Pathophysiology and Clinical Perspectives.

Wang Y, Liu S, Liu Q, Lv Y Front Physiol. 2022; 13:826686.

PMID: 35309079 PMC: 8931545. DOI: 10.3389/fphys.2022.826686.

Use of ultra high performance liquid chromatography with high resolution mass spectrometry to analyze urinary metabolome alterations following acute kidney injury in post-cardiac surgery patients.

Bai Y, Zhang H, Wu Z, Huang S, Luo Z, Wu K J Mass Spectrom Adv Clin Lab. 2022; 24:31-40.

PMID: 35252948 PMC: 8892161. DOI: 10.1016/j.jmsacl.2022.02.003.

Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients.

Hou Y, Deng Y, Hu L, He L, Yao F, Wang Y J Transl Int Med. 2022; 9(4):273-284.

PMID: 35136726 PMC: 8802406. DOI: 10.2478/jtim-2021-0047.

The incidence, risk factors and outcomes of acute kidney injury in critically ill patients undergoing emergency surgery: a prospective observational study.

Hu L, Gao L, Zhang D, Hou Y, He L, Zhang H BMC Nephrol. 2022; 23(1):42.

PMID: 35065624 PMC: 8782702. DOI: 10.1186/s12882-022-02675-0.

References

Segev G, Langston C, Takada K, Kass P, Cowgill L . Validation of a Clinical Scoring System for Outcome Prediction in Dogs with Acute Kidney Injury Managed by Hemodialysis. J Vet Intern Med. 2016; 30(3):803-7. PMC: 4913579. DOI: 10.1111/jvim.13930. View

Feng W, Rosca M, Fan Y, Hu Y, Feng P, Lee H . Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration. Hum Mol Genet. 2017; 26(7):1376-1390. PMC: 6075078. DOI: 10.1093/hmg/ddx040. View

Hu J, Wang Y, Geng X, Chen R, Xu X, Zhang X . Metabolic acidosis as a risk factor for the development of acute kidney injury and hospital mortality. Exp Ther Med. 2017; 13(5):2362-2374. PMC: 5443206. DOI: 10.3892/etm.2017.4292. View

Gong Y, Zhang F, Ding F, Gu Y . Elderly patients with acute kidney injury (AKI): clinical features and risk factors for mortality. Arch Gerontol Geriatr. 2011; 54(2):e47-51. DOI: 10.1016/j.archger.2011.05.011. View

Gullapalli R, Desai K, Santana-Santos L, Kant J, Becich M . Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. J Pathol Inform. 2012; 3:40. PMC: 3519097. DOI: 10.4103/2153-3539.103013. View

Chertow G, Burdick E, Honour M, Bonventre J, Bates D . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16(11):3365-70. DOI: 10.1681/ASN.2004090740. View

Linkermann A . Nonapoptotic cell death in acute kidney injury and transplantation. Kidney Int. 2016; 89(1):46-57. DOI: 10.1016/j.kint.2015.10.008. View

Idris-Khodja N, Ouerd S, Trindade M, Gornitsky J, Rehman A, Barhoumi T . Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation. J Hypertens. 2017; 35(7):1390-1401. PMC: 6338076. DOI: 10.1097/HJH.0000000000001324. View

Bienholz A, Petrat F, Wenzel P, Ickerott P, Weinberg J, Witzke O . Adverse effects of α-ketoglutarate/malate in a rat model of acute kidney injury. Am J Physiol Renal Physiol. 2012; 303(1):F56-63. PMC: 3431145. DOI: 10.1152/ajprenal.00070.2012. View

10.

Rigatto M, Behle T, Falci D, Freitas T, Lopes N, Nunes M . Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study. J Antimicrob Chemother. 2015; 70(5):1552-7. DOI: 10.1093/jac/dku561. View

11.

Sun C, Chang L, Sheu J, Wang C, Youssef A, Wu C . Losartan preserves integrity of cardiac gap junctions and PGC-1 alpha gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myocardial infarction. Int Heart J. 2007; 48(4):533-46. DOI: 10.1536/ihj.48.533. View

12.

Deng Y, Chi R, Chen S, Ye H, Yuan J, Wang L . Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study. Crit Care. 2017; 21(1):46. PMC: 5339963. DOI: 10.1186/s13054-017-1626-0. View

13.

Lameire N, Van Biesen W, Vanholder R . Acute renal failure. Lancet. 2005; 365(9457):417-30. DOI: 10.1016/S0140-6736(05)17831-3. View

14.

Sundararajan S, Gamboa J, Victor N, Wanderi E, Lust W, Landreth G . Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience. 2004; 130(3):685-96. DOI: 10.1016/j.neuroscience.2004.10.021. View

15.

Chinetti G, Fruchart J, Staels B . Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000; 49(10):497-505. DOI: 10.1007/s000110050622. View

16.

Kumari R, Manchanda S, Maulik S . Effect of pre- and posttreatment of losartan in feline model of myocardial ischemic-reperfusion injury. Methods Find Exp Clin Pharmacol. 2004; 26(1):39-45. DOI: 10.1358/mf.2004.26.1.793471. View

17.

Zhu W, Liu X, Wu N, Zhao T, Zhao Y, Zhang J . Beneficial effects of losartan on vascular injury induced by advanced glycosylation end products and their receptors in spontaneous hypertension rats. Mol Cell Biochem. 2007; 304(1-2):35-43. DOI: 10.1007/s11010-007-9483-9. View

18.

Yao S, Feng D, Wu Q, Li K, Wang L . Losartan attenuates ventilator-induced lung injury. J Surg Res. 2007; 145(1):25-32. DOI: 10.1016/j.jss.2007.03.075. View

19.

Sohotnik R, Nativ O, Abbasi A, Awad H, Frajewicki V, Bishara B . Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol. 2013; 304(8):F1099-104. DOI: 10.1152/ajprenal.00649.2012. View

20.

Chen Y, Yang Y, Miller M, Shen D, Shertzer H, Stringer K . Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology. 2007; 45(5):1118-28. DOI: 10.1002/hep.21635. View